JP6421124B2 - 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 - Google Patents

医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 Download PDF

Info

Publication number
JP6421124B2
JP6421124B2 JP2015540176A JP2015540176A JP6421124B2 JP 6421124 B2 JP6421124 B2 JP 6421124B2 JP 2015540176 A JP2015540176 A JP 2015540176A JP 2015540176 A JP2015540176 A JP 2015540176A JP 6421124 B2 JP6421124 B2 JP 6421124B2
Authority
JP
Japan
Prior art keywords
silica
food
range
pores
silica material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015540176A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015536939A (ja
JP2015536939A5 (enExample
Inventor
ロバート・サイカス
トーレ・ベングソン
ナタリア・クプフェルシュミット
アルフォンソ・イー・ガルシア−ベネット
Original Assignee
シグリッド・セラピューティクス・アーベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シグリッド・セラピューティクス・アーベー filed Critical シグリッド・セラピューティクス・アーベー
Publication of JP2015536939A publication Critical patent/JP2015536939A/ja
Publication of JP2015536939A5 publication Critical patent/JP2015536939A5/ja
Application granted granted Critical
Publication of JP6421124B2 publication Critical patent/JP6421124B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/015—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/12—Surface area
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/14—Pore volume
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/16—Pore diameter
    • C01P2006/17—Pore diameter distribution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Silicon Compounds (AREA)
JP2015540176A 2012-11-06 2013-11-06 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 Active JP6421124B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261723019P 2012-11-06 2012-11-06
US61/723,019 2012-11-06
PCT/EP2013/073200 WO2014072363A1 (en) 2012-11-06 2013-11-06 A porous silica material for use as a pharmaceutical or dietary active ingredient

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018194145A Division JP6752858B2 (ja) 2012-11-06 2018-10-15 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料

Publications (3)

Publication Number Publication Date
JP2015536939A JP2015536939A (ja) 2015-12-24
JP2015536939A5 JP2015536939A5 (enExample) 2016-12-22
JP6421124B2 true JP6421124B2 (ja) 2018-11-07

Family

ID=49639855

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015540176A Active JP6421124B2 (ja) 2012-11-06 2013-11-06 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料
JP2018194145A Active JP6752858B2 (ja) 2012-11-06 2018-10-15 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018194145A Active JP6752858B2 (ja) 2012-11-06 2018-10-15 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料

Country Status (20)

Country Link
US (2) US10695294B2 (enExample)
EP (2) EP3892285A3 (enExample)
JP (2) JP6421124B2 (enExample)
CN (2) CN105188720A (enExample)
AU (1) AU2013343565B2 (enExample)
BR (1) BR112015010118A2 (enExample)
CA (3) CA3024640A1 (enExample)
CY (1) CY1124471T1 (enExample)
DK (1) DK2916852T3 (enExample)
ES (1) ES2878017T3 (enExample)
HR (1) HRP20211036T1 (enExample)
HU (1) HUE055017T2 (enExample)
IL (1) IL238538B (enExample)
LT (1) LT2916852T (enExample)
PH (1) PH12015501010B1 (enExample)
PL (1) PL2916852T3 (enExample)
PT (1) PT2916852T (enExample)
SI (1) SI2916852T1 (enExample)
WO (1) WO2014072363A1 (enExample)
ZA (1) ZA201502979B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013343565B2 (en) 2012-11-06 2018-07-26 Sigrid Therapeutics Ab A porous silica material for use as a pharmaceutical or dietary active ingredient
TWI614017B (zh) 2012-12-21 2018-02-11 財團法人國家衛生研究院 包含中孔洞矽奈米粒子之組成物的用途
EP3651789A4 (en) * 2017-07-13 2021-05-26 Carnegie Mellon University METHOD OF INCREASING EPITHELIAL PERMEABILITY USING NANOPARTICLES
EA202091351A1 (ru) * 2017-12-13 2020-09-15 Л.И.Ко.Райс С.Р.Л. Комплекс лактоферрина и диоксида кремния, способ получения и композиции для гигиены полости рта
GB201803363D0 (en) 2018-03-01 2018-04-18 Sigrid Therapeutics Ab New materials and uses thereof
WO2020212418A1 (en) * 2019-04-15 2020-10-22 Nanologica Ab Empty porous particles for use in treatment, prevention and/or postponement of degeneration of neurodegenerative diseases, neurons and glia.
CN110314151B (zh) * 2019-08-02 2020-06-02 深圳国佳产业基金管理有限公司 医用介孔二氧化硅材料及其应用
CN114729263A (zh) * 2019-09-30 2022-07-08 零点火技术股份有限公司 隔热阻燃材料及其制造方法
JP7578945B2 (ja) * 2020-10-27 2024-11-07 信越化学工業株式会社 イミダゾールシラン処理シリカからなる胆汁酸吸着剤
CN114195885B (zh) * 2022-01-12 2024-04-26 杭州隆基生物技术有限公司 一种单克隆抗体组合物提纯方法
CN118871077A (zh) 2022-02-04 2024-10-29 西格丽德治疗公司 包含多孔二氧化硅颗粒的口腔护理组合物
JP2025119063A (ja) 2022-04-28 2025-08-14 日本たばこ産業株式会社 無機多孔質材料を含む口腔用組成物
GB202212240D0 (en) 2022-08-23 2022-10-05 Sigrid Therapeutics Ab New formulations and medical uses thereof
GB202212239D0 (en) 2022-08-23 2022-10-05 Sigrid Therapeutics Ab New dietary supplements
CN116747321B (zh) * 2023-06-14 2025-09-05 厦门君德医药科技有限公司 一种接枝改性的介孔二氧化硅及其制备方法和应用
GB202312179D0 (en) 2023-08-09 2023-09-20 Sigrid Therapeutics Ab New compositions and uses
GB202312176D0 (en) 2023-08-09 2023-09-20 Sigrid Therapeutics Ab New uses and methods

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185088A (en) 1977-02-17 1980-01-22 Merck & Co., Inc. Non-adhesive ionene quaternary polymer compositions useful as bile acid sequestrants
US4180566A (en) * 1978-05-15 1979-12-25 W. R. Grace & Co. Silica gel method of reducing blood lipid concentration
US4824672A (en) * 1986-06-06 1989-04-25 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
US5401466A (en) * 1993-06-01 1995-03-28 Miles Inc. Device for the direct measurement of low density lipoprotein cholesterol
EP0778027A3 (de) 1995-12-04 1998-04-01 Helmut Univ.-Prof. Dr. Wachter Verwendung von Kieselerde zur Herstellung von Arzneimitteln
EP0911078A1 (en) * 1997-10-20 1999-04-28 Hitachi Metals, Ltd. Photocatalyst-supporting body and photocatalytic apparatus
DK1093370T3 (da) * 1998-06-30 2006-05-22 Takeda Pharmaceutical Farmaceutisk præparat til behandling af diabetes
WO2001012221A1 (en) * 1999-08-16 2001-02-22 Henceforth Hibernia, Inc. Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them
RU2241462C2 (ru) 2000-07-28 2004-12-10 Ф. Хоффманн-Ля Рош Аг Новая фармацевтическая композиция
US7074440B2 (en) * 2002-05-01 2006-07-11 Rulin Xiu Compositions and methods for body weight loss
JP2004345895A (ja) * 2003-05-21 2004-12-09 Ajinomoto Co Inc メソポーラスシリカ及びその製造方法
JP2005289853A (ja) * 2004-03-31 2005-10-20 Ajinomoto Co Inc 経口リン酸吸着剤
GB0515353D0 (en) 2005-07-27 2005-08-31 Psimedica Ltd Food
KR100857411B1 (ko) 2006-07-21 2008-09-08 한올제약주식회사 리파아제 저해제의 경구 투여용 방출조절 약학 제제 및이의 제조 방법
CN101939258B (zh) 2008-02-11 2014-05-14 纳诺洛吉卡股份公司 中孔材料的制造方法、这样生产的材料以及中孔材料的用途
TW200936130A (en) * 2008-02-26 2009-09-01 Lundbeck & Co As H Uses of indane compounds
EP2271358B1 (en) * 2008-03-25 2018-11-21 Amarantus Therapeutics, Inc. use of mesencephalic astrocyte-derived neurotrophic factor for treating Parkinson's disease
JP2010065023A (ja) * 2008-08-14 2010-03-25 Lion Corp 脂溶性ビタミンおよび／または脂溶性色素含有粉体
EP2349336B1 (en) * 2008-10-28 2017-11-22 Agency For Science, Technology And Research Mesoporous material excipients for poorly aqueous soluble ingredients
DE102009026686A1 (de) * 2009-06-03 2010-12-23 Airbus France Anordnung zum Blitzschutz einer elektronischen Einheit
EP2547733A1 (en) 2010-03-17 2013-01-23 Nanologica AB Enhanced folic acid fluorescent material, multifluorescent porous compositions of matter and potential applications thereof
ES2768229T3 (es) * 2010-07-06 2020-06-22 Nanologica Ab Método mejorado para diferenciación de células madre in vivo mediante la administración de morfógenos con sílice mesoporosa y principios activos farmacéuticos correspondientes
GB201212866D0 (en) 2012-07-20 2012-09-05 Formac Pharmaceuticals Nv Dry granulates of mesoporous silica powders
AU2013343565B2 (en) 2012-11-06 2018-07-26 Sigrid Therapeutics Ab A porous silica material for use as a pharmaceutical or dietary active ingredient
EP2919903B1 (en) 2012-11-14 2020-07-22 W.R. Grace & CO. - CONN. Compositions containing a biologically active material and a non-ordered inorganic oxide
TWI614017B (zh) 2012-12-21 2018-02-11 財團法人國家衛生研究院 包含中孔洞矽奈米粒子之組成物的用途

Also Published As

Publication number Publication date
CA3024640A1 (en) 2014-05-15
PT2916852T (pt) 2021-06-15
JP2015536939A (ja) 2015-12-24
US10695294B2 (en) 2020-06-30
US12121612B2 (en) 2024-10-22
HRP20211036T1 (hr) 2021-10-01
PH12015501010A1 (en) 2015-07-27
CA3024460A1 (fr) 2018-11-15
CN113069467A (zh) 2021-07-06
ZA201502979B (en) 2024-09-25
CN105188720A (zh) 2015-12-23
PL2916852T3 (pl) 2021-11-02
PH12015501010B1 (en) 2023-10-20
EP3892285A3 (en) 2021-11-17
HUE055017T2 (hu) 2021-10-28
LT2916852T (lt) 2021-06-25
CA2890171A1 (en) 2014-05-15
IL238538A0 (en) 2015-06-30
EP2916852A1 (en) 2015-09-16
US20150258028A1 (en) 2015-09-17
BR112015010118A2 (pt) 2017-07-11
AU2013343565A1 (en) 2015-05-21
IL238538B (en) 2019-06-30
ES2878017T3 (es) 2021-11-18
US20200390703A1 (en) 2020-12-17
EP3892285A2 (en) 2021-10-13
EP2916852B1 (en) 2021-04-14
CA2890171C (en) 2019-01-22
AU2013343565B2 (en) 2018-07-26
CY1124471T1 (el) 2022-07-22
JP2019023222A (ja) 2019-02-14
DK2916852T3 (en) 2021-05-10
SI2916852T1 (sl) 2021-08-31
WO2014072363A1 (en) 2014-05-15
JP6752858B2 (ja) 2020-09-09

Similar Documents

Publication Publication Date Title
JP6752858B2 (ja) 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料
JP6196676B2 (ja) 官能化された炭酸カルシウムを含む速崩性固形投与製剤およびその製造方法
JP5240822B2 (ja) 多孔質セルロース凝集体及びその成型体組成物
CN101854912A (zh) 含贝特类药物和他汀类药物的组合的多相的纳米结构化的组合物
EA021313B1 (ru) Таблетки для комбинированной терапии
TW201641120A (zh) 可分散的劑型
TW200803752A (en) Food-and-drink composition improved in hygroscopicity
CN112351783A (zh) 氧化应激诱发的疾病的预防或治疗药物
CN102008477A (zh) 一种瑞舒伐他汀钙片药物组合物的制备方法
CN100477999C (zh) 胶体果胶铋分散片
Kumar et al. Modified release bi-layered tablet of melatonin using β-cyclodextrin
KR20190016216A (ko) 퀘세틴을 함유하는 나노에멀젼 조성물의 제조방법 및 이를 통해 제조된 퀘세틴을 함유하는 나노에멀젼 조성물
TWI644688B (zh) 含有崩解性粒子組成物之口腔內崩解錠劑之製造方法
JP2010163403A (ja) イソプラスタン低下剤
WO2019166656A1 (en) Highly structured porous silica materials and biological uses thereof
Sharma et al. Fast dissolving tablets of promethazine theoclate by using natural superdisintegrants
JP7267083B2 (ja) 還元型コエンザイムｑ１０を含む粉末組成物及び酸化防止剤
JP2005255618A (ja) 水難溶性活性成分および多孔質セルロース粒子含有固形製剤組成物。
JP2005255619A (ja) 昇華性活性成分および多孔質セルロース粒子含有固形製剤組成物
RU2646788C2 (ru) Применение соли альгината в качестве сорбента липидов, фармацевтическая композиция и лекарственный препарат для лечения ожирения
CN120771180A (zh) 一种用于缓解肥胖和/或促进肠道健康的组合物及用途
KR20250127825A (ko) 피부질환 개선효과를 가지는 테트라하이드로커큐민을 포함하는 탄산칼슘 마이크로입자의 제조방법
WO2016098459A1 (ja) 遅延崩壊性粒子組成物
JP2021187858A (ja) 医薬製剤
JP2007022981A (ja) 血中アンモニア低減剤および血中アンモニア低減性飲食品

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161101

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161101

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170828

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171002

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180104

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180604

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180914

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181015

R150 Certificate of patent or registration of utility model

Ref document number: 6421124

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250